World Kidney Day 2011 - Protect your kidneys, save your heart.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease.Archives of medical science : AMS · 2013
   Article
2. The risk of atherosclerosis in patients with chronic kidney disease.International urology and nephrology · 2013
   Article
3. Contrast-enhanced ultrasonography follow-up after radiofrequency ablation in normal rabbit kidney.Archives of medical science : AMS · 2013
   Article
4. Association of rs1800471 polymorphism of TGFB1 gene with chronic kidney disease occurrence and progression and hypertension appearance.Archives of medical science : AMS · 2013
   Article
5. Highlights of mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology.Archives of medical science : AMS · 2013
   Review
6. Vascular adhesion protein-1 and renalase in regard to diabetes in hemodialysis patients.Archives of medical science : AMS · 2012
   Article
7. Prevention of sudden cardiac death in patients with chronic kidney disease.BMC nephrology · 2012
   Review
8. Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions.Archives of medical science : AMS · 2011
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as